gliclazide has been researched along with barium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyle, JP; Doughty, JM; Langton, PD | 1 |
| Dusting, GJ; Jiang, F | 1 |
| Ahluwalia, A; Chauhan, S; Scotland, RS; Vallance, PJ | 1 |
3 other study(ies) available for gliclazide and barium
| Article | Year |
|---|---|
Blockade of chloride channels reveals relaxations of rat small mesenteric arteries to raised potassium.
Topics: Acetylcholine; Animals; Barium; Chloride Channels; Endothelium, Vascular; Gap Junctions; Glycyrrhetinic Acid; In Vitro Techniques; Male; Membrane Potentials; Mesenteric Arteries; Muscle Relaxation; Muscle, Smooth, Vascular; Nitrobenzenes; Osmolar Concentration; Potassium; Rats; Rats, Wistar | 2001 |
Endothelium-dependent vasorelaxation independent of nitric oxide and K(+) release in isolated renal arteries of rats.
Topics: Acetylcholine; Animals; Barium; Charybdotoxin; Dose-Response Relationship, Drug; Endothelium; Enzyme Inhibitors; Glycyrrhetinic Acid; In Vitro Techniques; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Ouabain; Oxadiazoles; Potassium; Quinoxalines; Rats; Rats, Inbred WKY; Renal Artery; Vasodilation; Vasodilator Agents | 2001 |
An endothelium-derived hyperpolarizing factor-like factor moderates myogenic constriction of mesenteric resistance arteries in the absence of endothelial nitric oxide synthase-derived nitric oxide.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Apamin; Barium; Biological Factors; Calcium; Charybdotoxin; Endothelium, Vascular; Enzyme Inhibitors; Female; Genotype; Glycyrrhetinic Acid; In Vitro Techniques; Indomethacin; Male; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Penicillamine; Potassium Channel Blockers; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2001 |